Neural cell Adhesion Molecule in human serum: increased levels in Dementia of the Alzheimer type

LAURA TODARO, LYDIA PURICELLI, HERNÁN GIOSEFFI, MARÍA G. PALLOTTA, JOSÉ M LASTIRI, ELISA BAL DE KIER JOFFÉ, MIRTA S. VARELA, EUGENIA S. DE LUSTIG.

NEUROBIOLOGY OF DISEASE

Elsevier

Lugar: Cambridge; Año: 2004 vol. 15 p. 387 - 393

0969-9961

Memory impairment is a process associated with alterations in neuronal plasticity, synapses formation, and stabilization. As the neural cell adhesion molecule (NCAM) plays a key role in synaptic bond stabilization, we analyzed the usefulness of soluble NCAM isoforms in the diagnosis of patients with dementia of the Alzheimer type (DAT). NCAM was measured in the sera of 70 control subjects and 43 DAT patients (with different severity of cognitive impairment, GDS), employing Western blot and densitometric quantification. LMW-NCAM bands (100-130 kDa) decreased significantly with age independently of sex. DAT patients presented values of LMW-NCAM and HMW-NCAM significantly higher than healthy controls of similar age (higher than 130 kDa). Only LMW-NCAM was associated with GDS. Our results suggest that NCAM could be involved in the pathogenesis of DAT disorder and that serum NCAM levels could be useful as differential diagnostic markers of the disease.